Vanda Pharma Q3 EPS $(0.37) Beats $(0.68) Estimate, Sales $69.815M Beat $69.202M Estimate

Vanda Pharma (NASDAQ:VNDA) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.68) by 45.59 percent. This is a 2.63 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $69.815 million which beat the analyst consensus estimate of $69.202 million by 0.89 percent. This is a 24.10 percent increase over sales of $56.258 million the same period last year.